http://www.oncternal.com
Oncternal Therapeutics, Inc. Company Intro
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
Industry
Healthcare
Oncternal Therapeutics, Inc. Headquaters
12230 El Camino Real
San Diego,92130
United States
Oncternal Therapeutics, Inc. Share price
22 Jan 2021 02:17 GMT
$5.72
0.14 (2.51 %)
Oncternal Therapeutics, Inc. Market cap
$269.679 M
WMC RANKING
2021
Oncternal Therapeutics, Inc. # 239
BiotechnologyLatest Oncternal Therapeutics, Inc. News
11 Jan 2021
Oncternal Therapeutics, Inc. (ONCT) climbs 9.69%, marking ...
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) has a beta value of 1.54 and has seen 1,768,976 shares traded in the recent trading session. The company ...
11 Jan 2021
Oncternal Therapeutics, Inc. (ONCT) climbs 9.69%, marking ...
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) has a beta value of 1.54 and has seen 1,768,976 shares traded in the recent trading session. The company ...
11 Jan 2021
Oncternal Therapeutics, Inc. (ONCT) climbs 9.69%, marking ...
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) has a beta value of 1.54 and has seen 1,768,976 shares traded in the recent trading session. The company ...
WMC Market Score
WMC Market to Revenue Score
Oncternal Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Oncternal Therapeutics, Inc. | USD | $2,425 | $35,533 | $-34,188 | $2,697M | 239 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Oncternal Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. Post vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Oncternal Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Oncternal Therapeutics, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 0 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALK-Abello A/S | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
